Ballentine Partners, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 34 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$56,436
-18.1%
143,6030.0%0.00%
-50.0%
Q4 2022$68,929
-71.3%
143,6030.0%0.00%
-75.0%
Q3 2022$240,000
-41.2%
143,6030.0%0.01%
-42.9%
Q2 2022$408,000
-43.5%
143,6030.0%0.01%
-39.1%
Q1 2022$722,000
-49.6%
143,6030.0%0.02%
-46.5%
Q4 2021$1,432,000
-23.3%
143,6030.0%0.04%
-31.7%
Q3 2021$1,867,000143,6030.06%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
TRB Advisors LP 550,000$8,751,0003.36%
Aperture Investors, LLC 469,584$7,471,0001.15%
Bleichroeder LP 810,416$13,088,0001.12%
SECTORAL ASSET MANAGEMENT INC 390,000$6,299,0000.48%
Monashee Investment Management LLC 125,000$2,019,0000.31%
MSD Partners, L.P. 388,691$6,277,0000.24%
Proficio Capital Partners LLC 111,559$1,802,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 150,000$2,387,0000.18%
Baupost Group 1,208,159$18,870,0000.15%
Pinz Capital Management, LP 24,900$402,0000.11%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders